Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755414 | SCV000605449 | likely benign | not provided | 2017-12-12 | criteria provided, single submitter | clinical testing | The p.Ala10Pro variant (rs1376436045) has not been reported in the medical literature nor listed in gene-specific variant databases. This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.5 percent in the African population (identified on 83 out of 15978 chromosomes) and has been reported to the ClinVar database (Variation ID: 440359). The alanine at codon 10 is weakly conserved considering 14 species (Alamut v2.10) and Wallaby has proline at this position. Computational analyses of the p.Ala10Pro variant on protein structure and function indicate a neutral effect (SIFT: tolerated, MutationTaster: polymorphism, PolyPhen-2: benign). Given the current evidence, this variant is considered to be likely benign. |
Gene |
RCV000508033 | SCV000723329 | likely benign | not specified | 2017-09-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001080634 | SCV001006431 | benign | Charcot-Marie-Tooth disease axonal type 2C | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001174124 | SCV001337245 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing |